Differential production of interleukin-3 in human T lymphocytes following either CD3 or CD2 receptor activation

D. Dilloo, U. Dirksen, M. Schneider, N. Zessack, B. Buttlies, L. Levitt, S. Burdach

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Interleukin-3 (IL-3) is expressed in T lymphocytes and stimulates the growth of multipotent hematopoietic progenitors. Little is known, however, about the stimuli that lead to IL-3 protein release. We examined IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA expression and protein secretion in human T lymphocytes following activation via the TCR/CD3 complex, the CD2 receptor, and the IL-2 receptor. GM-CSF mRNA expression and protein release were found in CD3- and CD2-activated T cells with maximum GM-CSF release following stimulation with IL-2. IL-3 protein release is regulated via the CD2-receptor with virtually no IL-3 release after T cell stimulation via CD3. In contrast, IL-3 mRNA accumulation is more pronounced after CD3 activation than after CD2 activation. This suggests that upregulation of IL-3 protein release following T cell stimulation via CD2 occurs largely at the translational or posttranslational level. These data also indicate that differential control of cytokine production can occur in response to activation of the alternative T cell receptor. Interaction of the T cell CD2-receptor with its natural ligand LFA-3 expressed on stromal cells might represent a regulatory mechanism for rapid release of IL-3, facilitating proliferation of multipotent hematopoietic cells.

Original languageEnglish
Pages (from-to)537-543
Number of pages7
JournalExperimental Hematology
Issue number4
StatePublished - 1996
Externally publishedYes


  • CD2
  • CD3
  • GM-CSF
  • IL-2
  • IL-3
  • T cells


Dive into the research topics of 'Differential production of interleukin-3 in human T lymphocytes following either CD3 or CD2 receptor activation'. Together they form a unique fingerprint.

Cite this